Point72 Asset Management
TNYA icon

Point72 Asset Management’s Tenaya Therapeutics TNYA Stock Holding History

Point72 Asset Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,475
Closed -$27.4K – 4504
2025
Q4 		$27.4K Buy
+38,475
New +$52.3K ﹤0.01% 3822

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's TNYA Position: Q1 2026 in Review

Point72 Asset Management sold out of Tenaya Therapeutics (TNYA) in Q1 2026, closing a stake of 38,475 shares — an estimated $27.4K sold.

Point72 Asset Management first reported a position in TNYA in Q4 2025 and held it in 1 quarter. The position peaked at $27.4K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Point72 Asset Management reported no remaining Tenaya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 38,475 Tenaya Therapeutics shares in Q1 2026, an estimated $27.4K.
  • Point72 Asset Management first reported a position in Tenaya Therapeutics in Q4 2025 and held it in 1 quarter.
  • Point72 Asset Management's Tenaya Therapeutics position peaked at $27.4K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.